Skip to main content

stock

INKT · MiNK Therapeutics, Inc.

What MiNK Therapeutics, Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live INKT price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on INKT.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
5,103,002 as of 2026-08-11 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
—
Net
—

Returns

ROE
—
ROA
-118.1%

Health

Current ratio
1.2x
Debt/equity
—

Deep value

NCAV
—
NCAV per share
—
Price/NCAV
Locked
NNWC
—
NNWC per share
—
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenue (not reported by this company)Gross profit (not reported by this company)Operating incomeNet incomeFiling
2026-06-30—Revenue: unreported by this company.—Gross profit: unreported by this company.-$3.22M-$3.13M
10-Q filed 2026-08-13
2026-03-31—Revenue: unreported by this company.—Gross profit: unreported by this company.-$2.88M-$2.74M
10-Q filed 2026-08-13
Assembled from more than one filing; the filing above is only the newest of them.
2025-12-31—Revenue: unreported by this company.—Gross profit: unreported by this company.-$2.71M-$2.60M
10-K filed 2026-03-31
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2025-09-30—Revenue: unreported by this company.—Gross profit: unreported by this company.-$3.18M-$2.89M
10-Q filed 2025-11-14
2025-06-30—Revenue: unreported by this company.—Gross profit: unreported by this company.-$4.05M-$4.24M
10-Q filed 2026-08-13
2025-03-31—Revenue: unreported by this company.—Gross profit: unreported by this company.-$2.70M-$2.77M
10-Q filed 2026-08-13
Assembled from more than one filing; the filing above is only the newest of them.
2024-12-31—Revenue: unreported by this company.—Gross profit: unreported by this company.-$2.50M-$2.46M
10-K filed 2026-03-31
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2024-09-30—Revenue: unreported by this company.—Gross profit: unreported by this company.-$1.88M-$1.81M
10-Q filed 2025-11-14
Assets
$9.62M
Equity
-$14.03M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31—-$12.64M-$12.49M—
2024-12-31—-$11.29M-$10.78M—
2023-12-31—-$22.92M-$22.46M-$15.84M
2022-12-31—-$30.95M-$27.99M-$19.12M
2021-12-31—-$28.36M-$30.21M-$13.08M
2020-12-31—-$14.64M-$16.24M-$8.43M

Company filings

since Wed Dec 10

events

  • Results

    Results
    Aug 138-K
  • Shareholder vote results

    Shareholder vote results
    Jun 238-K
  • Results

    Results
    May 158-K
  • Results

    Results
    Mar 318-K
  • Other event

    Other event
    Mar 278-K
  • Executive or director change

    Executive or director change
    Mar 198-K

Insiders, politicians and funds

Insider trades, last 90 days

No insider buys or sales filed in the last 90 days.

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named INKT, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about INKT.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about INKT.

nakagai

Signals on INKT come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the INKT board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

MiNK Therapeutics, Inc. (INKT): SEC filings, financials and insider trades · Nakagai